Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00005820 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: nitrocamptothecin

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]